Clinical Trial Details
EORTC-40015
Back to Clinical Trials Database
Irinotecan combined with infusional 5-FU/Folinic acid or Capecitabine and the role of Celecoxib in patients with metastatic colorectal cancer
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 21-May-2003 Date Step1 close: 12-Jan-2005 Date Step2 close: 12-Jan-2005 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 692 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00064181 |
| NCT number | NCT00064181 |
